Straumann Holding AG STMN.SW
Composite 54/100; the shares have moved about 35% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 29/100 — a moderate mark against it.
Balance-sheet strength ranks 76/100 — a strong point in its favour. Quality ranks 72/100 — a moderate point in its favour. Momentum ranks 52/100 — a slight point in its favour.
Valuation ranks 29/100 — a moderate mark against it. Growth ranks 36/100 — a moderate mark against it. Income ranks 38/100 — a moderate mark against it.
What the company does Straumann designs, manufactures and sells dental implants, CAD/CAM prosthetics, orthodontic aligners, biomaterials and digital equipment used in tooth replacement, restoration and prevention.
Key financials Straumann posts gross margin 70.1%, operating margin 23.8% and net margin 13.7%. ROE is 17.0%, ROA 11.1% and ROCE 39.6%. Revenue grew 2.2% while EPS fell -25.3%. Forward P/E is 30.03x and EV/EBITDA 24.46x.
Stock health Sustainability scores are strong: Quality 75.6, Strength 76.5, Altman Z 9.61, Debt/Equity 0.19 and Current ratio 2.21. Momentum is mixed: 3m +22.11%, 12m -5.62%, RSI 54.50.
Price vs fair value The stock trades at a PREMIUM of 71.20% versus our fair-value estimate and at a discount of 7.85% versus the analyst 12-month target. - Premium vs fair value reflects high multiples: P/E 45.43x, EV/EBITDA 24.46x, P/B 7.15x (Valuation 23.9/100) - Discount to target driven by 18.0 analyst coverage and 110.33 target price - Strong profitability (ROCE 39.6%) and quality (Quality 75.6) support valuation
Looking forward Forward P/E of 30.03x and PEG of 0.59 imply growth is already discounted, while revenue growth of 2.2% and EPS decline of -25.3% suggest execution risk.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.